DE3575721D1 - Pyrimidinonderivate, deren herstellung und verwendung. - Google Patents

Pyrimidinonderivate, deren herstellung und verwendung.

Info

Publication number
DE3575721D1
DE3575721D1 DE8585304332T DE3575721T DE3575721D1 DE 3575721 D1 DE3575721 D1 DE 3575721D1 DE 8585304332 T DE8585304332 T DE 8585304332T DE 3575721 T DE3575721 T DE 3575721T DE 3575721 D1 DE3575721 D1 DE 3575721D1
Authority
DE
Germany
Prior art keywords
production
pyrimidine derivatives
pyrimidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585304332T
Other languages
English (en)
Inventor
Takao Takaya
Masayoshi Murata
Kiyotaka Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848416140A external-priority patent/GB8416140D0/en
Priority claimed from GB848423438A external-priority patent/GB8423438D0/en
Priority claimed from GB848427122A external-priority patent/GB8427122D0/en
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE3575721D1 publication Critical patent/DE3575721D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585304332T 1984-06-25 1985-06-17 Pyrimidinonderivate, deren herstellung und verwendung. Expired - Fee Related DE3575721D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB848416140A GB8416140D0 (en) 1984-06-25 1984-06-25 Pyrimidinone derivatives
GB848423438A GB8423438D0 (en) 1984-09-17 1984-09-17 Pyrimidinone derivatives
GB848427122A GB8427122D0 (en) 1984-10-26 1984-10-26 Pyrimidinone derivatives

Publications (1)

Publication Number Publication Date
DE3575721D1 true DE3575721D1 (de) 1990-03-08

Family

ID=27262396

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585304332T Expired - Fee Related DE3575721D1 (de) 1984-06-25 1985-06-17 Pyrimidinonderivate, deren herstellung und verwendung.

Country Status (3)

Country Link
US (1) US4649142A (de)
EP (1) EP0166564B1 (de)
DE (1) DE3575721D1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708958A (en) * 1986-09-24 1987-11-24 G. D. Searle & Co. 6-(imidazolyphenyl)-4-iminopyrimidinones useful as hypotensive agents
US7501429B2 (en) * 2001-04-11 2009-03-10 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
JP2004536071A (ja) * 2001-05-25 2004-12-02 クイーンズ　ユニバーシティ　アット　キングストン 複素環ベータアミノ酸およびそれらの抗癲癇誘発剤としての使用
JP2010532350A (ja) * 2007-06-29 2010-10-07 コレア リサーチ インスティテュート オブ ケミカル テクノロジー 新規のｈｉｖ逆転写酵素阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612376A (en) * 1983-03-25 1986-09-16 Fujisawa Pharmaceutical Co., Ltd. Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent

Also Published As

Publication number Publication date
US4649142A (en) 1987-03-10
EP0166564B1 (de) 1990-01-31
EP0166564A3 (en) 1986-10-29
EP0166564A2 (de) 1986-01-02

Similar Documents

Publication Publication Date Title
DE3682654D1 (de) Acylaminosiliciumverbindungen, deren verwendung und herstellung.
DE3674089D1 (de) Thiazolidin-derivate, deren herstellung und verwendung.
DE3578418D1 (de) Chinonderivate, ihre herstellung und verwendung.
ATE89560T1 (de) Makrolid-derivate, ihre herstellung und ihre verwendung.
DE3680251D1 (de) Fluorpolymerzusammensetzungen, deren herstellung und verwendung.
DE3667998D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3579888D1 (de) Carbapenemverbindungen und deren herstellung.
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
DE3777366D1 (de) 2,3-dihydro-cumaron-derivate, ihre herstellung und verwendung.
DE3587366D1 (de) Benzimidazol-derivate, ihre herstellung und verwendung.
DE3581255D1 (de) Dns, deren herstellung und verwendung.
DE3687130D1 (de) Pyrazolderivate, deren herstellung und verwendung.
DE3765682D1 (de) Thiolactam-n-essigsaeure-derivate, ihre herstellung und verwendung.
DE3668326D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3577719D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3584410D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3784602D1 (de) Inonos-derivate, ihre herstellung und verwendung.
DE3577707D1 (de) 3-pyrazolo(1,5-a)pyridinium-cephemverbindungen, deren herstellung und verwendung.
DE3669323D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3484531D1 (de) Tetrahydrobenzotriazole, deren herstellung und verwendung.
DE3673474D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
ATE29881T1 (de) 4-hydroxy-2h-1-benzothiopyran-derivate, deren herstellungen und verwendungen.
DE3669518D1 (de) Vollaromatische polyester, deren herstellung und verwendung.
DE3575302D1 (de) Tetrahydrophthalimide, deren herstellung und deren verwendung.
DE3577870D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee